BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12902428)

  • 1. A Bayesian 3-compartment model for 99mTc-MAG3 clearance.
    Russell CD
    J Nucl Med; 2003 Aug; 44(8):1357-61. PubMed ID: 12902428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of single plasma sample methods to estimate renal clearance using 99mTc-ethylenedicysteine and 99mTc-mercaptoacetyltriglycine.
    Sohaib M; Rafique A; Saeed S; Afshan A
    Clin Physiol Funct Imaging; 2013 Sep; 33(5):353-8. PubMed ID: 23701132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of technetium-99m mercaptoacetyltriglycine clearance in patients with impaired renal function.
    Erdil TY; Dede F; Tuglular S; Sen F; Ones T; Farsakoglu Z; Inanir S; Ozener C; Akoglu E; Turoglu T
    Nucl Med Commun; 2006 Feb; 27(2):191-6. PubMed ID: 16404234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of the influence of total renal function on renal output efficiency and normalized residual activity.
    Nimmon CC; Sámal M; Britton KE
    J Nucl Med; 2004 Apr; 45(4):587-93. PubMed ID: 15073254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administered activity optimization in 99mTc-MAG3 renography for adults.
    Díaz MP; Aparicio EE; Rizo OD; Díaz RR; Rodríguez CH
    J Nucl Med Technol; 2003 Dec; 31(4):216-21. PubMed ID: 14657288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-injection, two-sample method for measuring renal 99mTc-MAG3 clearance in both children and adults.
    Russell CD; Taylor AT; Dubovsky EV; Eshima D
    Nucl Med Biol; 1995 Jan; 22(1):55-60. PubMed ID: 7735170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of arteriovenous difference in measuring renal function by single-injection plasma clearance: role of bolus.
    Russell CD; Dubovsky EV
    Nucl Med Biol; 1999 Aug; 26(6):699-705. PubMed ID: 10587110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise acutely increases renal transit time of Tc-99m mercaptoacetyltriglycine (MAG3) in a post-liver transplant patient.
    Murthy R; Chahal M; Appel G; Bergmann S; Tikofsky R; Fawwaz R; Van Heertum R
    Clin Nucl Med; 2006 Dec; 31(12):829-34. PubMed ID: 17117088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of 99mTc-MAG3 clearance by single-sample methods and camera-based methods.
    Inoue Y; Yoshikawa K; Yokoyama I; Ohtomo K
    Ann Nucl Med; 2000 Oct; 14(5):329-32. PubMed ID: 11108160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of extrarenal plasma clearance and hepatic uptake of technetium-99m-mercaptoacetyltriglycine in cats.
    Drost WT; McLoughlin MA; Mattoon JS; Lerche P; Samii VF; DiBartola SP; Chew DJ; Barthez PY
    Am J Vet Res; 2003 Sep; 64(9):1076-80. PubMed ID: 13677382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc-MAG3 renography: normal values for MAG3 clearance and curve parameters, excretory parameters, and residual urine volume.
    Esteves FP; Taylor A; Manatunga A; Folks RD; Krishnan M; Garcia EV
    AJR Am J Roentgenol; 2006 Dec; 187(6):W610-7. PubMed ID: 17114514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The single-plasma-sample method for determining the glomerular filtration rate with Tc-99m-diethylenetriamine pentaacetic acid in childhood and adolescence: is it age-dependent?
    Itoh K; Matsuyama T
    Ann Nucl Med; 2002 Dec; 16(8):541-8. PubMed ID: 12593419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of single sample methods for determination of plasma clearance using 99mTc-MAG3].
    Itoh K; Tsukamoto E; Mochizuki T; Kanegae K; Katoh C; Tamaki N
    Kaku Igaku; 1998 Oct; 35(8):689-95. PubMed ID: 9847510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Improved the accuracy of 99mTc-MAG3 plasma clearance method: the problem of the calculated plasma volume and its modification].
    Watanabe N; Takahashi K; Komatani A; Yamaguchi K
    Kaku Igaku; 1998 Oct; 35(8):741-7. PubMed ID: 9847517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of (99m)Tc-MAG3.
    Vivier PH; Dacher JN
    AJR Am J Roentgenol; 2009 Oct; 193(4):W361; author reply W362. PubMed ID: 19770310
    [No Abstract]   [Full Text] [Related]  

  • 16. Measurement of renal function with technetium-99m-MAG3 in children and adults.
    Russell CD; Taylor AT; Dubovsky EV
    J Nucl Med; 1996 Apr; 37(4):588-93. PubMed ID: 8691246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiopharmacokinetics, renal clearance and dosimetry of 99mTc-MAG3.
    Arteaga de Murphy C; Molina-Trinidad E; Meléndez-Alafort L; Ferro-Flores G; Reyes-Herrera L; Sepúlveda-Méndez J; Sandoval-Guzmán B; Hoyo-Vadillo C
    Arch Med Res; 1999; 30(1):49-54. PubMed ID: 10071425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive measurement of renal function with 99mTc-MAG3 gamma-camera renography based on the one-compartment model.
    Oriuchi N; Onishi Y; Kitamura H; Inoue T; Tomaru Y; Higuchi T; Inoue T; Endo K
    Clin Nephrol; 1998 Nov; 50(5):289-94. PubMed ID: 9840316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of technetium-99m-MAG3 renal clearance in children: two gamma camera techniques compared with multiple plasma samples.
    Gordon I; Anderson PJ; Orton M; Evans K
    J Nucl Med; 1991 Sep; 32(9):1704-8. PubMed ID: 1831838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calculation of renal retention function without deconvolution.
    Kuyvenhoven JD; Ham HR; Piepsz A
    Nucl Med Commun; 2003 Oct; 24(10):1097-103. PubMed ID: 14508166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.